title: [Characteristics of Ca(2+)-induced response of erythrocytes in patients with lung cancer during antineoplastic chemotherapy].
authors.forename: I V
authors.initials: IV
authors.lastname: Petrova
authors.forename: E A
authors.initials: EA
authors.lastname: Stepovaia
authors.forename: I B
authors.initials: IB
authors.lastname: Sokolova
authors.forename: V E
authors.initials: VE
authors.lastname: Gol'dberg
authors.forename: N Iu
authors.initials: NIu
authors.lastname: Chasovskikh
authors.forename: K G
authors.initials: KG
authors.lastname: Koreshkova
authors.forename: N G
authors.initials: NG
authors.lastname: Bazhenova
authors.forename: M V
authors.initials: MV
authors.lastname: Kolosova
authors.forename: M B
authors.initials: MB
authors.lastname: Baskakov
authors.forename: V V
authors.initials: VV
authors.lastname: Novitskiĭ
authors.forename: M A
authors.initials: MA
authors.lastname: Medvedev
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002118:Calcium / Q000378:metabolism*; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology; D018288:Carcinoma, Small Cell / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D008727:Methotrexate / Q000008:administration & dosage; D015221:Potassium Channels / Q000378:metabolism
chemical_list: D015221:Potassium Channels; D004317:Doxorubicin; D003520:Cyclophosphamide; D002118:Calcium; D008727:Methotrexate